SeaCrest Wealth Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,770
Closed -$108K 1005
2022
Q2
$108K Buy
+5,770
New +$114K 0.01% 830
2019
Q2
Sell
-3,279
Closed -$67K 1095
2019
Q1
$67K Sell
3,279
-286
-8% -$5.85K 0.01% 834
2018
Q4
$64K Sell
3,565
-325
-8% -$6.65K 0.01% 818
2018
Q3
$90K Sell
3,890
-275
-7% -$6.23K 0.02% 783
2018
Q2
$90K Sell
4,165
-197
-5% -$4.19K 0.02% 756
2018
Q1
$94K Sell
4,362
-995
-19% -$22.9K 0.02% 725
2017
Q4
$121K Buy
+5,357
New +$125K 0.02% 646

Other funds holding HQH

SeaCrest Wealth Management's HQH Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of abrdn Healthcare Investors (HQH) in Q3 2022, closing a stake of 5,770 shares — an estimated $108K sold.

SeaCrest Wealth Management first reported a position in HQH in Q4 2017 and held it in 7 quarters. The position peaked at $121K in Q4 2017. 105 funds tracked by Wall St. Rank hold HQH as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining abrdn Healthcare Investors position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 5,770 abrdn Healthcare Investors shares in Q3 2022, an estimated $108K.
  • SeaCrest Wealth Management first reported a position in abrdn Healthcare Investors in Q4 2017 and held it in 7 quarters.
  • SeaCrest Wealth Management's abrdn Healthcare Investors position peaked at $121K in Q4 2017.
  • 105 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.